Table 4 Clinical data of the patients in the PP and GP group
|  | PP group (n = 30) | GP group (n = 88) | P |
|---|---|---|---|
Age (years) | 57.9 ± 8.7 | 56.2 ± 9.8 | 0.379 |
Sex, male (%) | 22 (73.3%) | 75 (85.2%) | 0.232 |
Extensive anterior wall MI(n) | 9 (30.0%) | 18 (20.5%) | 0.410 |
Killip class ≥II (n) | 6 (20.0%) | 11 (12.5%) | 0.478 |
Stenotic vessels ≥2 (n) | 24 (80.0%) | 73 (83.0%) | 0.929 |
WBC(109/L), median (IQR) | 8.8 (7.5, 12.0) | 9.4 (7.8, 10.9) | 0.800 |
HGB(g/L) | 139.9 ± 20.7 | 147.4 ± 16.1 | 0.080 |
Cr (umol/L), median (IQR) | 77.1 (69.7, 85.5) | 75.4 (63.3, 85.0) | 0.636 |
AST(U/L), median (IQR) | 58.3 (26.6, 156.1) | 60.5 (28.8, 113.2) | 0.858 |
ALT(U/L), median (IQR) | 41.3 (22.4, 64.1) | 37.5 (22.6, 58.4) | 0.807 |
TC (mmol/L), median (IQR) | 4.5 (4.1, 4.7) | 4.5 (3.9, 5.1) | 0.961 |
HDL-C (mmol/L), median (IQR) | 1.1 (0.9, 1.2) | 1.0 (0.9, 1.3) | 0.683 |
LDL-C (mmol/L), median (IQR) | 2.7 (2.4, 3.1) | 3.0 (2.4, 3.5) | 0.232 |
Fasting blood sugar (mmol/L), median (IQR) | 6.0 (5.0, 7.3) | 6.1 (5.2, 7.6) | 0.663 |